Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Molecular Cancer Therapeutics|December 29, 2011
Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancerJing Chen, Jieqiong Wang, Lei Lin, et al.Oncogene|April 5, 2023
Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS<sup>G12D</sup> inhibitor efficacy in KRAS<sup>G12D</sup>-mutated colorectal cancerJuanjuan Feng, Zhongwei Hu, Xinting Xia, et al.European Journal of Medicinal Chemistry|October 17, 2021
Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitorsBei-Er Jiang, Jiaxin Hu, Hao Liu, et al.Carcinogenesis|March 24, 2011
1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathwayXiufeng Pang, Li Zhang, Li Lai, et al.Probiotics and Antimicrobial Proteins|April 16, 2025
Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa CellsHaoran Li, Dongyuan Zhou, Weiquan Wang, et al.Journal of Medicinal Chemistry|May 2, 2023
Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi ResistancePeng He, Juanjuan Feng, Xinting Xia, et al.Elife|May 3, 2022
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stressYanan Liu, Juanjuan Feng, Kun Yuan, et al.Oncotarget|December 8, 2016
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathwayKun Li, Qunfeng Guo, Jun Yang, et al.The Journal of Clinical Investigation|January 4, 2021
BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitorsJiawei Guo, Yanan Liu, Jing Lv, et al.Acta Pharmaceutica Sinica. B|March 27, 2023
Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in <i>KRAS</i>-mutant lung cancerJuanjuan Feng, Zhengke Lian, Xinting Xia, et al.Pageof 7